TRIAL NUMBER

STATUS

PATIENT

CONDITION

DRUG

DELIVERY ROUTE

END POINT

NCT 00520780

(FAIR-HF)

COMPLETED

456

HF, ID, IDA

FCM

i.v.

SELF-REPORTED PATIENT GLOBAL ASSESSMENT (PGA)

AND NYHA FUNCTIONAL STATUS 24 WEEKS AFTER INITIATION OF THERAPY

NCT03036462

RECRUITING

1200

HF

FCM

i.v.

RECURRENT HF HOSPITALIZATIONS

AND CARDIOVASCULAR DEATH (NUMBER OF EVENTS)

NCT02937454 (AFFIRM-HF STUDY)

COMPLETED

1132

HF

FCM

i.v.

HF HOSPITALIZATIONS AND CV DEATH.

NCT02642562

(IRONMAN)

COMPLETED

1160

HF, LVSD

FERRIC DERISOMALTOSE

i.v.

CV MORTALITY OR HOSPEDALIZATION FOR WORSENING HF

NCT03344523

UNKNOWN

600

HF

IRON PROTEIN SUCCINYLATE

oral

PERFORMANCE OF 6 MINUTE WALK DISTANCE

NCT05702970

NOT YET RECRUITING

258

HF

SUCROSOMIAL IRON, VIT D FCM

oral, i.v.

PERFORMANCE OF THE SIX-MINUTE WALKING TEST,

NCT01453608 (CONFIRM-HF)

COMPLETED

304

HF

FCM

i.v.

EXERCISE CAPACITY (CHANGE IN SIX MINUTE WALK TEST

FROM BASELINE TO WEEK 24)

NCT05691257

NOT YET RECRUITING

300

HF, ANEMIA IN CHRONIC KIDNEY DISEASE

RECOMBINANT HUMAN EYTHROPOIETIN, FERROUS SUCCINATE, POLYSACCHARIDE IRON COMPLEX, IRON SUCROSE

oral, i.v.

CHANGE IN HEMOGLOBIN FROM BASELINE

NCT05793996

RECRUITING

100

HF

FCM

i.v.

QUALITY OF LIFE INDICATORS

NCT05759078

RECRUITING

2000

MI

FCM

i.v.

THE RISK OF CV DEATH, HF EVENTS

NCT04786769

NOT YET RECRUITING

2500

AS

FCM

i.v.

HOSPITAL ADMISSION OR CV DEATH IN TAVI OR SAVR

PATIENTS

NCT05697211

RECRUITING

50

HF

FERRIC MALTOL

oral

THE SAFETY, TOLERABILITY AND EFFICACY OF

ORAL FERRIC MALTOL

NCT04945707

(IRONMET-HFpEF)

RECRUITING

66

HF

FERRIC DERISOMALTOSE

i.v.

CHANGE IN PEAK OXYGEN UPTAKE FROM BASELINE TO WEEK 12

NCT03380520

COMPLETED

75

HF

FCM

i.v.

CHANGE IN LVEF FROM BASELINE

NCT03398681

COMPLETED

53

HF

FCM

i.v.

CHANGES IN MYOCARDIAL IRON CONTENT